This is the last of the three-part podcast series, Keeping up with the Chemos on lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the challenges with patient monitoring while on lenvatinib/pembrolizumab.  The panel discusses personal clinical experiences and lessons learned, most common adverse events seen with the medication drug, and when to dose adjust and hold or even discontinue lenvatinib/pembrolizumab. Once again, the session ends with take home points for at home supportive care regimen(s) while on lenvatinib/pembrolizumab.2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith Smith, PharmDSpeakers:Jennifer MacDonald, PharmD, BCOPPamela Soliman, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.